A Diagnostic Breakthrough for Alzheimer’s with Dr. Jonathon Hill
BioTalk Unzipped1 Kesä 2024

A Diagnostic Breakthrough for Alzheimer’s with Dr. Jonathon Hill

A Diagnostic Breakthrough for Alzheimer’s

Summary

In this conversation, Dr. Jonathan Hill discusses his work in nanopore sequencing-based technology and its applications in genetic and epigenetic research. He shares his experiences working in Brazil and his passion for preserving the rainforest. The conversation also explores the use of AI in analyzing the genetic underpinnings of tobacco addiction and the potential impact on addiction treatment. Dr. Hill highlights his lab's breakthrough in identifying early biomarkers for Alzheimer's disease using DNA methylation signatures.

Takeaways

  • Nanopore sequencing is a powerful technology that allows for real-time analysis of native DNA and RNA, regardless of length, and provides valuable insights into genetic and epigenetic research.

  • Preserving the rainforest is crucial, and initiatives like the Rainforest Trust play a vital role in protecting the biodiversity and resources found in these ecosystems.

  • AI technologies, when used in conjunction with genetic research, can accelerate the identification of candidate genes associated with complex conditions like tobacco addiction, leading to personalized approaches for smoking cessation and addiction treatment.

  • The integration of AI technologies in genetic research should be approached with caution, as the black box nature of AI can limit our understanding of the underlying biology. It is important to carefully test and explain AI models to build trust among users.

  • The use of nanopore sequencing and DNA methylation signatures shows promise in the early detection of Alzheimer's disease, potentially allowing for personalized approaches to treatment and intervention.


Sound Bites

  • "One of my bucket list items, one of my dreams would be to set up a nanopore sequencing lab in the Amazon and just sequence that biodiversity and create that data so we could glean it for everything it's worth and learn so much about how our world works."

  • "Nanopore sequencing is based on protein nanopores that exist in nature, and these particular nanopores can pass DNA through the pore."

  • "AI technologies, when used in conjunction with genetic research, can accelerate the identification of candidate genes associated with complex conditions like tobacco addiction, leading to personalized approaches for smoking cessation and addiction treatment."

  • “Biology is not rocket science, it’s much harder.”

  • "Better diagnosis comes better treatment."


Chapters

00:00 Introduction

02:51 Donation to the Rainforest Trust & Time in Brazil

06:37 How Nanopore Sequencing Works

12:45 New News! AI and the Genetic Code of Tobacco Addiction

15:20 Using AI in Nanopore Sequencing at Wasatch Labs and Diagnostics

21:14 Finding Cell-Free DNA for Fertility Treatments

22:56 Breakthrough - Finding Early Biomarkers for Alzheimer’s


New News Article

Breaking the Genetic Code of Tobacco Addiction

https://neurosciencenews.com/genetics-tobacco-addiction-ai-25937/


How to reach us:

Dr. Jonathan Hill

https://www.linkedin.com/in/jonathon-t-hill/

Wasatch Labs: https://www.wasatchbiolabs.com/

Dr. Chad Briscoe

https://www.linkedin.com/in/chadbriscoe/

Celerion - https://www.celerion.com/

Gregory Austin

https://www.linkedin.com/in/gregoryaustin1/

ECI - https://eci-rx.com /


Image Credits

Rainforest Trust - https://www.rainforesttrust.org/

https://www.envirobuild.com/blog/rainforest-trust

Fire Sponge

https://stock.adobe.com/

Amazon

Photos: Shutterstock

Medicine Man

https://www.rollingstone.com/music/music-lists/stills-from-the-movie-medicine-man-32217/medicine-man-5-159239/

https://www.solarnavigator.net/films_movies_actors/medicine_man.htm

Oxford Nanopore Technologies

How nanopore sequencing works

https://www.youtube.com/watch?v=RcP85JHLmnI


Keywords

nanopore sequencing, genetic research, epigenetics, rainforest preservation, AI, tobacco addiction, addiction treatment, Alzheimer's disease, DNA methylation

#nanopore, #geneticresearch, #epigenetics, #AI, #addiction, #alzheimers, #DNA

Jaksot(41)

How AI is Helping Diagnose Disease with Chuck Piccirillo

How AI is Helping Diagnose Disease with Chuck Piccirillo

Summary In this conversation, Gregory Austin and Chad Briscoe interview Chuck Piccirillo, CEO of Zealic Health, about his experience in the healthcare industry and the focus on patient-centric soluti...

2 Elo 202438min

Reptiles, Treatments, and Cell-Gene Therapy with Dr. Vick

Reptiles, Treatments, and Cell-Gene Therapy with Dr. Vick

Summary Dr. Andy Vick shares some of the things that surprised him throughout his career and he discusses his passion for reptiles and his experience discussing the pharmaceutical potential of venom w...

15 Heinä 202438min

Amyloidosis Exposed: New Hope with Dr. Vick

Amyloidosis Exposed: New Hope with Dr. Vick

Summary Dr. Andy Vick discusses his work at Attralus Therapeutics, a biotech company focused on developing treatments for systemic amyloidosis. He explains the etiology of the disease and how Attralus...

1 Heinä 202440min

The AI Prescription: Revolutionizing Pharma & Patient Care with Jason Burke

The AI Prescription: Revolutionizing Pharma & Patient Care with Jason Burke

The AI Prescription: Revolutionizing Pharma & Patient Care with Jason Burke Summary In Episode 13, Jason Burke discusses the unique approach of the Duke program in providing real-world healthcare data...

15 Touko 202435min

Unlocking the Future of Healthcare with Organoids, AI, and Quantum Computing with Jason Burke

Unlocking the Future of Healthcare with Organoids, AI, and Quantum Computing with Jason Burke

Summary In this episode of BioTalk Unzipped, the hosts discuss the applications and ethical concerns surrounding organoids, which are 3D cell clusters that mimic the features of full-sized organs. The...

1 Touko 202434min

Breakthrough in Melanoma, Rare Diseases, and Curative Therapies with Scott Schliebner

Breakthrough in Melanoma, Rare Diseases, and Curative Therapies with Scott Schliebner

Summary In this episode, Scott Schliebner discusses the unique challenges and complexities of rare disease trials. He highlights the difficulties in recruiting patients, the multidisciplinary nature o...

15 Huhti 202436min

Impact of AI in Rare Disease Trials with Scott Schliebner

Impact of AI in Rare Disease Trials with Scott Schliebner

Impact of AI in Rare Disease Trials with Scott Schliebner Summary In this episode, the hosts welcome Scott Schliebner as their guest and kick off with a charitable act, donating to Rare Givers. They d...

1 Huhti 202436min

Suosittua kategoriassa Liike-elämä ja talous

sijotuskasti
mimmit-sijoittaa
rss-rahapodi
psykopodiaa-podcast
herrasmieshakkerit
rss-lahtijat
leadcast
rahapuhetta
rss-seuraava-potilas
ostan-asuntoja-podcast
inderespodi
rss-rahamania
rss-porssipuhetta
rss-laakispodi
rss-vaikuttavan-opettajan-vierella
rss-karon-grilli
rss-juurisyy-johtamisesta-kilpailuetua
rss-40-ajatusta-aanesta
rss-porssipodi
rss-johtoajatuksia